LCD L38333: MolDX: Blood Product Molecular Antigen Typing — Noridian
Policy LCD-L38333 · Infectious Disease / Microbiology
New MolDX guidelines affect blood product billing.
Code intelligence
Policy changes, MAC LCD updates, and CMS guidance matched to code 0084U.
Signal breakdown
9 shown · 9 total in platform
Critical
0%
High
67%
Routine
33%
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Policy LCD-L38333 · Infectious Disease / Microbiology
New MolDX guidelines affect blood product billing.
Policy LCD-L38331 · Infectious Disease / Microbiology
Prepare for updated billing practices for antigen typing tests.
Policy LCD-L36256 · Clinical Laboratory
New molecular diagnostics policy may impact billing processes.
Policy LCD-L36021 · Clinical Laboratory
New MolDX policy effective in 2025 may alter billing processes.
Policy LCD-L35160 · Clinical Laboratory
New MolDX guidelines may alter MDT billing processes.
Policy LCD-L38249 · Infectious Disease / Microbiology
Prepare for changes in blood product billing effective 2026.
Policy LCD-L38351 · Oncology
New guidelines for repeat germline testing could impact reimbursements.
Policy LCD-L38288 · Oncology
New LCD may impact repeat germline testing reimbursements.
Policy LCD-L38353 · Clinical Laboratory
New LCD on germline testing impacts billing practices.
Audit documentation
The Tripwire Audit Pack exports 12 months of Infectious Disease / Microbiology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.